Clover Health Investments, Corp.

CLOV

US18914F1030

Managed Healthcare

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
1.02 ^USD	+11.88%		+37.84%	+7.13%

May. 07	Transcript : Clover Health Investments, Corp., Q1 2024 Earnings Call, May 07, 2024
May. 07	Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Posts Q1 Revenue $346.9M, vs. Street Est of $321.2M	MT

Clover Health Investments, Corp. Appoints Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage

January 10, 2023 at 09:17 am EST

Clover Health Investments, Corp. announced that on January 6, 2023, the Board of Directors of the company appointed Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage, effective immediately. Ms. Reynoso had previously served as Chief Operating Officer of the Company.

Latest news about Clover Health Investments, Corp.

Transcript : Clover Health Investments, Corp., Q1 2024 Earnings Call, May 07, 2024	May. 07
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Posts Q1 Revenue $346.9M, vs. Street Est of $321.2M	May. 07	MT
Clover Health Investments, Corp. announces an Equity Buyback for $20 million worth of its shares.	May. 07	CI
Clover Health Investments, Corp. Updates Earnings Guidance for the Full Year 2024	May. 07	CI
Clover Health Investments, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Clover Health Investments, Corp. authorizes a Buyback Plan.	May. 05	CI
Clover Health Investments, Corp. Announces Management Changes	Apr. 22	CI
Clover Health Investments, Corp. Announces CFO Changes	Apr. 22	CI
Clover Health Launches New Clinical Program in Partnership with quarter Health to Address Serious Mental Illness	Mar. 19	CI
Clover Health Investments, Corp.(NasdaqGS:CLOV) dropped from S&P Health Care Services Select Industry Index	Mar. 17	CI
Transcript : Clover Health Investments, Corp., Q4 2023 Earnings Call, Mar 12, 2024	Mar. 12
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Reports Q4 Revenue $510.3M, vs. Street Est of $474M	Mar. 12	MT
Clover Health Investments, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Clover Health Investments, Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 12	CI
Clover Health Investments, Corp. Reports Impairment of Goodwill and Other Intangible Assets for the Fourth Quarter Ended December 31, 2023	Mar. 12	CI
Clover Health Investments, Corp. Provides Revenue Guidance for the Full Year 2024	Mar. 12	CI
Clay Thornton Joins Clover Health as CFO of Medicare Advantage Division	Mar. 07	CI
North American Morning Briefing : Stock Futures -2-	Feb. 27	DJ
Transcript : Clover Health Investments, Corp. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:00 AM	Jan. 11
Clover Health Investments Names Terrence Ronan as Interim Chief Financial Officer	Dec. 27	MT
Clover Health Investments, Corp. Announces Management Changes	Dec. 27	CI
Clover Health Investments, Corp. Appoints Terrence Ronan as Interim Chief Financial Officer, Effective January 27, 2024	Dec. 27	CI
Clover Health Investments, Corp. Announces Resignation of Scott J. Leffler as Chief Financial Officer, Effective January 26, 2024	Dec. 21	CI
Transcript : Clover Health Investments, Corp., Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Posts Q3 Revenue $482.1M, vs. Street Est of $494.6M	Nov. 06	MT

Chart Clover Health Investments, Corp.

Duration

Period

More charts

Company Profile

Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program. The Companyâs subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC.

Sector

Managed Healthcare

Calendar

2024-05-14 - BofA Securities Health Care Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Clover Health Investments, Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.9117 USD

Average target price

1.333 USD

Spread / Average Target

+46.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

	1st Jan change	Capi.
CLOVER HEALTH INVESTMENTS, CORP.	+7.13%	452M
UNITEDHEALTH GROUP INC.	-2.39%	471B
ELEVANCE HEALTH, INC.	+13.37%	125B
CIGNA	+15.69%	99.18B
CENTENE CORPORATION	+3.58%	41.17B
MOLINA HEALTHCARE, INC.	-3.14%	20.65B
PROGYNY, INC.	-26.09%	2.61B
ALIGNMENT HEALTHCARE, INC.	-18.70%	1.32B

Other Managed Healthcare